This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,270.95, is for the delivery of SKYLA 13.5 MG SYSTEMS, a pharmaceutical product, with a performance period through May 13, 2024.
The contract is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, under the SPE2DB program. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group provides a wide array of medications, including both common and specialized pharmaceutical products, to support the diverse medical needs of military personnel and their dependents across various Department of Defense (DoD) healthcare facilities through this vehicle.
Generated 7/22/24, 9:17 AM